Wnt5a is one of the most extensively studied proteins of the Wnt family and is known to play an important role in cellular motility and proliferation. Wnt5a is a ligand of the receptor tyrosine kinase-like orphan receptor 1 (ROR1), an onco-embryonic protein expressed on chronic lymphocytic leukemia (CLL) B cells, and on a variety of solid tumors, but not on normal adult tissues. This mini-review summarizes recent results regarding the inhibition of effects of Wnt5a signaling by targeting ROR1.
In humans, Wnt family proteins consist of 19 members that have important roles in the regulation of diverse processes including cell proliferation, survival, migration and metastasis [1] [2] [3] . Three Wnt signaling pathways have been characterized [4] [5] [6] ; (i) canonical Wnt pathway: Also known as the Wnt/β-catenin pathway, which causes an accumulation of β-catenin in the cytoplasm and its eventual translocation into the nucleus to act as a transcriptional coactivator of transcription factors that belong to the TCF/LEF (T-cell factor/lymphoid enhancing factor) family.
(ii) noncanonical planar cell polarity (PCP) pathway: The PCP pathway is activated via the binding of Wnt to a Frizzled (FZD) receptor. The receptor then recruits Dishevelled (Dsh), which forms a complex with Dishevelled-associated activator of morphogenesis 1 (DAAM1) that activates the small G-protein Rho through a guanine exchange factor. Wnt signaling pathways are potential therapeutic targets in cancer 6 . Wnt5a, one of the members of the Wnt family, has been shown to have a crucial role in cellular proliferation and motility 7, 8 . Altered expression of Wnt5a is significantly related to poor clinical outcome in chronic lymphocytic leukemia (CLL), ovarian and gastric cancer [9] [10] [11] . Fukuda et al. showed that Wnt5a is a ligand of receptor tyrosine kinase-like orphan receptor 1 (ROR1) 12 .
ROR1 is a transmembrane protein, comprised of an extracellular domain consisting of an immunoglobulin-like motif, a cysteine-rich frizzled domain, a kringle domain, a cytoplasmic tyrosine kinase domain, two serine/threonine-rich domains and a proline-rich domain 13 . This protein is expressed during embryogenesis, playing a key role in skeletal and neural organogenesis. ROR1 expression attenuates during fetal development, and with a few exceptions 14 , is not expressed in normal post-partum tissues 12 . As a receptor for Wnt5a, ROR1 can induce non-canonical signaling to promote such oncogenic activities. ROR1 is expressed on CLL B cells, as well as on several solid tumors [15] [16] [17] [18] , and its expression is associated with markers of epithelial-mesenchymal transition (EMT), cancer-cell motility/invasiveness, metastatic disease, and poor prognosis 19, 20 . . In this study, Choi et al. performed a Good Laboratory Practice-compliant human tissue cross-reactivity study using UC-961, and identified ROR1 in pancreatic cancer cells, but not in normal postpartum tissues, including the pancreas or adipose tissue. The authors also conducted rodent and primate studies to assess for off-target or non ROR1-specific activity, and found UC-961 was well tolerated and no adverse effects were observed. They also performed studies in cynomolgus monkeys using UC-961, and observed no changes in body weight, clinical chemistry values, or hematologic parameters, including absolute numbers of T or B cells. 
